REGULATORY PERSPECTIVES OF PHARMACEUTICAL PRODUCTS IN GHANA

Journal Title: International Journal of Drug Regulatory Affairs - Year 2014, Vol 2, Issue 2

Abstract

Drug Registration is a procedure of expertise of pharmaceutical product quality, efficacy and safety by the Regulatory Authority. The emergence of various formats has enabled the manufacturers of the drug to easily gain access into various markets and thus was able to place their products into the market. The choice of Ghana as one of the destinations for the market of the Drug products ensures the manufacturer a good market value. Ghana is considered as one of the growing pharmaceutical market in east Africa. Of late, generic drugs are holding a major stake in the pharmaceutical market and are gaining more and more confidence in the usage. Majority of medicines in the Ghana are generic drugs which are considered as value for the money and affordable. With Ghana Regulatory Authority is the Food and Drugs Board, which takes decision to register the product and issues Registration Certificate. This study mainly focuses on the regulatory environment, registration process involved and the regulatory requirements that are applicable for the generic drug products in Ghana.

Authors and Affiliations

Raja Mohan Reddy. G, Venkatesh M. P, Pramod Kumar T. M.

Keywords

Related Articles

STATUS OF A T POLYMORPHISM IN EXON II OF KINASE INSERT DOMAIN GENE IN WOMEN WITH PREMATURE OVARIAN FAILURE

Ovarian failure is defined as cessation of ovarian function under the age of 40 and it is characterized by amenorrhea hypo estrogenism and elevated gonadotrophin serum levels leading to infertility. Ovarian failure affec...

DRUG PRODUCT REGISTRATION IN SEMI-REGULATED MARKET

There found a diversity of regulatory requirement in Semi regulated market. This region consists of mainly the countries from Asia pacific, Latin America, Eastern Europe, Africa and Gulf countries. Countries from Asia pa...

ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF DILTIAZEM HYDROCHLORIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM BY RP- HPLC

A simple, specific, precise and accurate Reverse Phase High Performance Liquid Chromatography (RP-HPLC) method was developed and validated for the estimation of Diltiazem Hydrochloride in bulk and pharmaceutical dosage f...

Drug approval process in US, Europe and India and its regulatory requirements: A Review

Current constrain of Regulatory Affairs reveals diverse countries need to follow different regulatory requirements for marketing authorization Application (MAA) approval of new drugs. In this present exertion, study expr...

UNDERSTANDING TECHNICAL BARRIERS TO TRADE AGREEMENT

Signing of formation of World Trade Organization has transformed trade, services and intellectual property into a mutual, predictable exchange of trade and intellectual property protection among member countries. Countri...

Download PDF file
  • EP ID EP345407
  • DOI 10.22270/ijdra.v2i2.126
  • Views 110
  • Downloads 0

How To Cite

Raja Mohan Reddy. G, Venkatesh M. P, Pramod Kumar T. M. (2014). REGULATORY PERSPECTIVES OF PHARMACEUTICAL PRODUCTS IN GHANA. International Journal of Drug Regulatory Affairs, 2(2), 7-15. https://europub.co.uk/articles/-A-345407